ilmscore | Prediction Details
By CA Rachana Phadke Ranade | April 26, 2023 | Pending
Interpreted Prediction
Mankind Pharma's post-IPO shareholding will require a further 1.5% dilution within three years to comply with SEBI regulations, potentially leading to a slight correction in share prices due to increased supply.

Prediction Details

Comments

0 comments

Be the first to share your thoughts.

Like this prediction?

Join to make your opinion count.